Rob Ford undergoing chemotherapy for 2 tumours, Doug Ford says

Coun. Rob Ford is undergoing chemotherapy for two tumours attached to the bladder, not one as initially reported, his brother Doug Ford says.

Councillor admitted to Mount Sinai Hospital

Rob Ford is undergoing chemotherapy for a tumour discovered on his bladder, his staff say. (CBC)

Coun. Rob Ford is undergoing chemotherapy for two tumours attached to his bladder, not one as initially reported, his brother Doug Ford says.

The former mayor visited the hospital "several times" this week and is undergoing additional tests, according to a statement from his office. He has been admitted to Mount Sinai Hospital, the statement said.

According to the statement, they "still do not have definitive test results indicating if there is any organ involvement, or the size of the tumours." 

Last week, the councillor and his brother, Doug Ford, announced the discovery of a new tumour, revealing Rob Ford had been in "excruciating pain" for several weeks.

At the time, Doug Ford said the tumour appeared "consistent with the previous tumour." However, Rob Ford later said they were still awaiting biopsy results to determine whether the new tumour is malignant. 

"We're praying that it's benign, but you gotta deal with the realistic part of things, and I'm 99 per cent sure it's malignant," he said last week.

Ford underwent surgery in May to remove a large cancerous tumour from his abdomen. 

Comments

To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.